September 18, 2024
FDA heightened label warnings about hepatic injury and increased the required frequency of liver function testing after initiation of fezolinetant.
September 17, 2024
Those least likely to schedule further screening mammograms had received a false-positive with recommendation for follow-up after only a short interval.
September 17, 2024
Presented at ESMO, the findings reflect “a highly discriminate blood-based panel of methylated DNA markers” as well as a robust new marker class for identifying patients with precancerous lesions.
September 16, 2024
Among those treated with lebrikizumab, more than one-third saw clear/almost clear skin at week 16; three-quarters of them maintained results at week 52 with monthly dosing.
September 16, 2024
Individuals with migraine who failed to respond to up to 4 previous migraine preventive treatments saw fewer monthly migraine and headache days after 1 infusion of Lu AG90222.
September 13, 2024
The approval makes dupilumab available to treat uncontrolled CRSwNP in adolescents aged 12 to 17 years, expanding on the current approved range of 18 years and older.
September 13, 2024
Unawareness was highest among the youngest adults, aged 18 to 44 years, an age range where CV health should be optimized to avoid later morbidity, researchers wrote.
September 12, 2024
The term "flare" is used consistently in discussions of AD, but is everyone talking about the same thing? New research closes in on a patient-centered definition.
September 12, 2024
The GSK reformulation induced acceptable immune responses for both influenza A and B strains, overcoming a setback earlier in the ability to successfully neutralize the latter.
September 11, 2024
The needle-free nasal spray, if approved, would be the first new administration method for epinephrine in young children in 35 years.